Shares of Cencora Inc. COR rose 1.68% to $290.22 Friday, on what proved to be an all-around positive trading session for the ...

Cencora is an established healthcare distributor, which can capture market demand, and is a proven dividend grower. Learn why ...

Buying $100 In COR: If an investor had bought $100 of COR stock 5 years ago, it would be worth $313.24 today based on a price ...

Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.

Shares of Cencora Inc. COR slipped 1.63% to $278.38 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to 5,844.19 and ...

Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsBennett Murphy - Senior Vice President, Head of ...

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally ...

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company. With a market cap ...

NEW YORK - J.P. Morgan Securities plc has announced that it may take actions to stabilize the market price of Cencora, Inc.’s newly offered securities, which include EUR 3-year and 7-year fixed ...

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the firm ...

U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

Dive into top trends shaping the biopharma industry with STAT and experts, who will share practical insights and ...